Vaxcyte
Price & Volume
Stats
See more52W Range | $27.66-$76.61 |
Market Cap | $8.8B |
Shares Short | 11M |
Financials
See moreRevenue (12 Mos) | $0 |
Revenue Growth (YoY) | 0% |
Gross Profit (12 Mos) | -$75M |
Diluted EPS | -$4.85 |
News
See moreYahoo Finance • 11 days ago
Impressive Clinical Pipeline Leads to Bullish Sentiment for Vaxcyte (PCVX)
Yahoo Finance • 16 days ago
Vaxcyte Doses First Participants in OPUS-3 Phase 3 Trial Evaluating VAX-31 in Adults Previously Vaccinated with Lower-Valency Pneumococcal Vaccines
Yahoo Finance • 25 days ago
Vaxcyte Funding And Late-Stage Trials Put Valuation In Focus
Yahoo Finance • 2 months ago
What Makes Vaxcyte (PCVX) So Attractive
About
CEO | Mr. Grant E. Pickering M.B.A. |
CFO | Mr. Andrew L. Guggenhime M.B.A. |
Address | 825 Industrial Road, San Carlos, CA, United States, 94070 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 414 |
